Help us: Donate
Follow us on:
×

Tag: Oliver Medvedik

Journal Club
Journal Club, hosted by Dr. Oliver Medvedik, will return on July 26, 2022 12:00 PM Eastern Time. This month, we are going to be taking a look at a recent paper where researchers showed that old human skin rejuvenated when implanted in young mice [1]. The study helps to pave the way for therapies that...
Journal Club
Journal Club returns on Tuesday, April 26th at noon Eastern time on our Facebook page. Dr. Oliver Medvedik will be taking a look at the recent paper 'The hyperfunction theory: an emerging paradigm for the biology of aging'. This episode sees us taking a dive into the world of aging theory and a look at...
Journal Club
The next Journal Club will be on Tuesday 2nd November and Dr. Oliver Medvedik will be taking a look at a new paper called “Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker“. Join us live on Facebook at 1 PM Eastern US time on Tuesday November 2nd. Abstract A...
Journal Club
Journal Club returns live to our Facebook channel on June 29th at noon Eastern Time with Dr. Oliver Medvedik. This month, we are taking a look at rapamycin, a drug that has long been believed to slow down aging, and how it changes the way DNA is stored inside cells to support gut health and...
Journal Club
The Journal Club hosted by Dr. Oliver Medvedik returns for another episode on May 25th at noon Eastern / 5 UK time live on our Facebook page. This month, we have one of the authors, Dr. Vadim Gladyshev, joining us, and he will be talking us through this new research. Vadim and his team report...
Journal Club
Join Dr. Oliver Medvedik at 12:00 Eastern, February 25th for the Journal Club livestreamed on our Facebook page. Researchers have discovered that mitochondria trigger cellular senescence through communication with the cell's nucleus and identified that a HDAC inhibitor, an FDA-approved drug, helped suppress the damaging effects of the condition in cells and mice. The discovery...

Want the latest longevity news? Subscribe to our Newsletter!